Chicago Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Chicago Capital Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-190,000	Closed	-$5.76M	–	29
2026 Q1	$5.76M	Buy	+190,000	New	+$4.09M	4.77%	11

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Chicago Capital Management's APLS Position: Q2 2026 in Review

Chicago Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 190,000 shares — an estimated $5.76M sold.

Chicago Capital Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $5.76M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Chicago Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Chicago Capital Management sold 190,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $5.76M.
Chicago Capital Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Chicago Capital Management's Apellis Pharmaceuticals position peaked at $5.76M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Chicago Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.